AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
GLP1 medications have evolved over time, transitioning from daily to monthly dosing with improved side effect profiles. The medications are now categorized as anti-obesity drugs and show significant promise for weight loss, unlike previous disappointing outcomes in the field of obesity treatment.